TREE NEWS update: Johnson & Johnson will acquire biopharmaceutical company Ollin Biosciences for up to $3.33 billion. The deal value was reported by Bloomberg. No further terms of the transaction were disclosed.
Johnson & Johnson to acquire Ollin Biosciences for up to $3.33B
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
8m ago
Bank of America CEO Moynihan: Some M&A Deals Pushed to 2027; Investors Cite Anthropic IPO
10m ago
Tesla to invest €3 billion in Berlin expansion for Cybercab production
34m ago
Global Markets: Nvidia Earnings Eve Sees Tech Stocks Slide, Nasdaq Futures Down 1.4%
1h ago
Chinese Listed Firms Address Nvidia Event Impact on Compute Supply Chains
1h ago
Bank of America CEO: Capital Markets Activity Has Been Very Volatile
1h ago
Strive buys 251 BTC for $17.5M, holdings reach 43,404 BTC